<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical risk scores for patients with colorectal liver metastases</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical risk scores for patients with colorectal liver metastases</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clinical risk scores for patients with colorectal liver metastases</div><div class="cntnt"><table cellspacing="0"><colgroup width="15%"></colgroup><colgroup width="50%"></colgroup><colgroup width="35%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Criteria (1 point assigned for each risk factor)</td> <td class="subtitle1">Risk groups</td> </tr> <tr> <td>Fong<sup>[1]</sup></td> <td> <ol class="numbers_to_nine"> <li>Disease-free interval &lt;12 months </li> <li>Number of metastases &gt;1 </li> <li>Preoperative CEA level &gt;200 ng/mL </li> <li>Largest liver metastasis &gt;5 cm </li> <li>Lymph node positive primary tumor </li> </ol> </td> <td> <p>Low: 0 to 2 points</p> High: 3 to 5 points </td> </tr> <tr> <td>Nordlinger<sup>[2]</sup></td> <td> <ol class="numbers_to_nine"> <li>Age &gt;60 </li> <li>Serosal invasion of the primary tumor (&gt;pT3) </li> <li>Lymph node positive primary tumor </li> <li>Disease-free interval &lt;24 months </li> <li>Number of liver metastases &gt;3 </li> <li>Largest liver metastasis &gt;5 cm </li> </ol> </td> <td> <p>Low: 0 to 2 points</p> <p>Intermediate: 3 to 4 points</p> High: 5 to 6 points </td> </tr> <tr> <td>Nagashima<sup>[3]</sup></td> <td> <ol class="numbers_to_nine"> <li>Serosal invasion of primary tumor (&gt;pT3) </li> <li>Lymph node positive primary tumor </li> <li>Number of liver metastases ≥2 </li> <li>Largest liver metastasis &gt;5 cm </li> <li>Resectable extrahepatic metastases </li> </ol> </td> <td> <p>Low: 0 to 1 points</p> <p>Intermediate: 2 to 3 points</p> High: ≥4 points </td> </tr> <tr> <td>Konopke<sup>[4]</sup></td> <td> <ol class="numbers_to_nine"> <li>Number of liver metastases ≥4 </li> <li>CEA ≥200 ng/mL </li> <li>Synchronous liver metastases </li> </ol> </td> <td> <p>Low: 0 points</p> <p>Intermediate: 1 point</p> High: ≥2 points </td> </tr> </tbody></table></div><div class="graphic_lgnd">Four clinical risk scores are commonly calculated for patients with colorectal liver metastases to predict prognosis after liver resection; all were developed in patients undergoing surgery without prior chemotherapy. Refer to the associated UpToDate topic for detailed discussion of how clinical risk scores should be used in the modern era of neoadjuvant therapy. </div><div class="graphic_footnotes">CEA: carcinoembryonic antigen.</div><div class="graphic_reference">References:

<ol>
<li>Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309.</li>
<li>Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77:1254.</li>
<li>Nagashima I, Takada T, Adachi M, et al. Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors. World J Gastroenterol 2006; 12:6305.</li>
<li>Konopke R, Kersting S, Distler M, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 2009; 29:89.</li>
</ol>

Reproduced from: Wimmer K, Schwarz C, Szabo C, et al. Impact of neoadjuvant chemotherapy on clinical risk scores and survival in patients with colorectal liver metastases. Ann Surg Oncol 2017; 24:236. Copyright © 2017 Wimmer K, Schwarz C, Szabo C, et al. Available at: <a href="https://link.springer.com/article/10.1245%2Fs10434-016-5615-3" target="_blank">https://link.springer.com/article/10.1245%2Fs10434-016-5615-3</a> (Accessed on February 23, 2018). Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License</a>.</div><div id="graphicVersion">Graphic 116620 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
